Stock Watch: Johnson & Johnson’s Q2 Helps Pharma Sentiment
After The Post-Pandemic Sell-Off, Investors Could Be Returning To The Sector
Pharmaceutical stocks have underperformed in the year to date, but J&J, Novartis and GSK may have started to turn the worm.
